Agata Stodolna

A little science geek who after uni becomes a confectioner, shoes and food lover ;)

[Agata Stodolna @LadySciencee]

@adbeggs @H_L_Robbins @CRUKresearch Congratulation @H_L_Robbins 🥳

[Nonacus @NonacusLtd]

Thank you UoB for your hard work and dedication.

Nonacus are driven to reduce the need for painful, invasive testing when a patient presents blood in their urine. Revolutionary genetic testing comes with collaborating with experts like Dr Doug Ward

[Moved on to @parafilmm.bsky.social @ParafilmM]

Parafilm
P a r a f i l m
P a r a f i l m
P a r a f i l m
P a r a f i l m
P a r a f i l m
P a r a f i l m

[Nonacus @NonacusLtd]

Does your #NGS panel reliably detect CNVs for germline and somatic mutations? If not, check out our posters from ESHG.

GALEAS® Tumor https://t.co/XKFiAvTSPg
GALEAS® Hereditary Plus https://t.co/CD3Z2zVw9q

[Nonacus @NonacusLtd]

Today is World DNA day: an event that honours two significant milestones — the 1953 discovery of DNA structure and the completion of the Human Genome Project in April 2003. Without these pivotal events modern genomic understanding would not be where it is today.

#worlddnaday

[Oded Rechavi @OdedRechavi]

Nature Biotechnology papers

[Nonacus @NonacusLtd]

Team Nonacus are ready for Day 1 at the Festival of Genomics. If you're attending, be sure to stop by our Booth (36) to learn more about our targeted NGS solutions for liquid biopsy and our *new* Custom MRD panels for Minimal Residual Disease detection.

#fog2022

[Agata Stodolna @LadySciencee]

This was such a nice way to celebrate 🥰#PhDone

[Nonacus @NonacusLtd]

We are delighted to announce that we have been awarded third place in Deloitte's annual UK Technology Fast 50 awards.

To read more, please click the link below:

https://t.co/qYnRuA8O2u

#UKFast50

[Nonacus @NonacusLtd]

The Cell3™ Target Bladder Cancer panel is a targeted NGS panel that covers the majority of somatic mutations found in bladder cancer. The latest results found that it was able to detect 144 out of the 165 people with bladder cancer that had haematuria, with sensitivity of 87.3%

[Nonacus @NonacusLtd]

In our latest blog post we discuss the importance of differentiation between the common winter viruses Covid-19, Flu and RSV, and their respective but often overlapping symptoms.

https://t.co/DCyCF1khWX

[Nonacus @NonacusLtd]

Next week Nonacus will be in attendance at The Crick Institute Cancer Research Symposium. This year's event, between 3-4 October, will consider multiple angles of cancer research and provide a forum for lively discussion. To arrange an appointment email [email protected].

[Agata Stodolna @LadySciencee]

@Dr_Kasun @adbeggs @beggs_lab Congratulations! 🥳

[Simon Holland @simoncholland]

You know you’re a grownup when catching up on sleep means going to bed at 8 instead of sleeping in until 10.

[Agata Stodolna @LadySciencee]

Furthermore, thank you @UoB_CCB for support, guidance and help with data analysis. I would not be able to have this work without an increadible bioinformatics support

[Agata Stodolna @LadySciencee]

I passed my viva today with minor corrections 🥳 thank you to @adbeggs and @beggs_lab for the support, opportunities and an amazing years! Dr Stodolna has a nice ring to it, although my favourite is Dr Mummy as my daughter called me today 🥺

[Andrew Beggs @adbeggs]

Congrats to Agata @LadySciencee from @beggs_lab for passing her thesis with minor corrections! Thanks also to Dion Morton, Tim Maughan from @UniofOxford and Deena Gendoo for chairing!

Agata started the work in our lab on radiosensitivity and organoids:

[Nonacus @NonacusLtd]

Sequence up to 30% more variants than other exome captures without increasing your sequencing costs. Introducing our new clinically enhanced human exome capture panel, Cell3™ Target: Nexome, designed to confidently call CNVs, SNVs and Indels with high recall and precision.

[Andrew Beggs @adbeggs]

We’ve just published a new paper in @FrontOncology arising from work from my previous @CRUKresearch funded ACSF award?
Headline finding: dual PI3K/AKT inhibitors significantly radiosensitise both irradiated and tx naive PDO models of rectal cancer (1/n)

https://t.co/a5yJqpj1iZ